Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization

Kasper Aanaes1, Helle Krogh Johansen, Steen Seier Poulsen

  • 1Department of Otolaryngology - Head & Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Copenhagen, Denmark. Kasperaanaes@hotmail.com

Abstract

Insights

Pseudomonas aeruginosa sinusitis may precede lung colonization in cystic fibrosis (CF) patients. Elevated specific IgA in nasal secretions and saliva can help distinguish CF patients with different P. aeruginosa lung infection statuses.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonology

Background:

  • Pseudomonas aeruginosa lung colonization is a concern in cystic fibrosis (CF).
  • Sinusitis caused by P. aeruginosa may lead to increased IgA in respiratory secretions.
  • This study investigates the link between P. aeruginosa sinusitis and lung colonization in CF patients.

Purpose of the Study:

  • To determine if P. aeruginosa sinusitis is associated with intermittent or chronic lung colonization in CF patients.
  • To evaluate the diagnostic potential of specific IgA antibodies in nasal secretions and saliva for differentiating CF patient infection states.

Main Methods:

  • Cross-sectional study of 120 CF patients with varying P. aeruginosa lung infection statuses.
  • Measurement of IgA and IgG antibodies against P. aeruginosa sonicate and alginate.
  • ELISA analysis of antibodies in nasal secretions, saliva, and serum.

Main Results:

  • Intermittently colonized CF patients showed significantly higher IgA levels in nasal secretions and saliva compared to non-colonized patients.
  • These findings suggest P. aeruginosa sinusitis may precede intermittent lung colonization and chronic infection.
  • Specific IgA levels correlate with P. aeruginosa lung colonization status in CF.

Conclusions:

  • Specific IgA against P. aeruginosa in nasal secretions and saliva can differentiate between CF patients with chronic infection, intermittent colonization, or no lung P. aeruginosa.
  • The diagnostic utility of IgA ELISA for P. aeruginosa infection states in CF requires further validation through prospective studies.